scholarly journals Dental Pulp Cells Produce Neurotrophic Factors, Interact with Trigeminal Neurons in Vitro, and Rescue Motoneurons after Spinal Cord Injury

2001 ◽  
Vol 238 (1) ◽  
pp. 120-132 ◽  
Author(s):  
Irina V. Nosrat ◽  
Johan Widenfalk ◽  
Lars Olson ◽  
Christopher A. Nosrat
2011 ◽  
Vol 28 (9) ◽  
pp. 1939-1949 ◽  
Author(s):  
Fernanda Martins de Almeida ◽  
Suelen Adriani Marques ◽  
Bruna dos Santos Ramalho ◽  
Rafaela Fintelman Rodrigues ◽  
Daniel Veloso Cadilhe ◽  
...  

2018 ◽  
Vol 37 (3) ◽  
pp. 467-474 ◽  
Author(s):  
Ken Sugiyama ◽  
Kosuke Nagashima ◽  
Takahiro Miwa ◽  
Yuta Shimizu ◽  
Tomoko Kawaguchi ◽  
...  

2021 ◽  
Author(s):  
Shuo Liu ◽  
Caixia Fan ◽  
Yuanyuan Xie ◽  
Liudi Wang ◽  
Yanyan Cui ◽  
...  

Abstract ObjectiveCell-based therapy is a promising strategy for spinal cord injury (SCI) repair, but faced the challenges to direct the neuronal differentiation of appropriate neuron subtypes for achieving the neuronal replacement. We investigated whether allogeneic beforehand in vitro differentiated neural stem cells (NSCs) could relieve the adverse effects of regeneration inhibitory niche and promote motor functional recovery by accomplishing neuronal replacement after transplant into SCI rats. MethodsCollagen scaffold combined with digested NSCs, NSC sphere, differentiated neurons, and sphere of differentiated neurons were transplanted into completely transected SCI in rats and therapeutic outcomes were investigated. Next, we enriched complex of neurotrophic factors secreted from culture medium of NSCs, neurons, and sphere of neurons and a total of 2 mg total enriched protein combined with collagen scaffold were transplanted into SCI to further assay whether allogeneic NSCs transplant promotes the recovery of SCI predominantly by secreting neurotrophic factors. ResultsNSCs differentiated into neurons in density-dependent manner in vitro and sphere of NSCs could counteract myelin-induced inhibition of neuronal differentiation. Collagen scaffold combined with digested NSCs, NSC sphere, differentiated neurons, and sphere of differentiated neurons were transplanted into completely transected SCI in rats. Overall the cell treatment groups had a much better locomotor recovery, tissue remodeling, and newborn neuron formation than alone collagen scaffold treatment, compared with alone collagen material transplant and control group. However, unexpectedly, the differentiated cell treatment (differentiated neurons and sphere of differentiated neurons transplants) did not present striking better locomotor recovery than the undifferentiated NSCs and sphere of NSCs treatments, only sphere of neurons showed a slight increase in BBB score compared to other cell treatments. Next, we enriched complex of neurotrophic factors secreted from culture medium of NSCs, neurons, and sphere of neurons. BBB score analysis showed that the secreted neurotrophic factors from NSCs, neurons, and sphere of neurons would promote functional recovery of SCI to the same extent. ConclusionAllogeneic NSCs transplant promotes functional recovery of SCI predominantly by secreting neurotrophic factors, not direct neuronal replacement of differentiated neurons from transplanted cells.


2021 ◽  
Vol 116 ◽  
pp. 101978
Author(s):  
Reza Asadi-Golshan ◽  
Vahid Razban ◽  
Esmaeil Mirzaei ◽  
Abdolkarim Rahmanian ◽  
Sahar Khajeh ◽  
...  

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Sheng-Yu Cui ◽  
Wei Zhang ◽  
Zhi-Ming Cui ◽  
Hong Yi ◽  
Da-Wei Xu ◽  
...  

Abstract Background Spinal cord injury (SCI) is associated with health burden both at personal and societal levels. Recent assessments on the role of lncRNAs in SCI regulation have matured. Therefore, to comprehensively explore the function of lncRNA LEF1-AS1 in SCI, there is an urgent need to understand its occurrence and development. Methods Using in vitro experiments, we used lipopolysaccharide (LPS) to treat and establish the SCI model primarily on microglial cells. Gain- and loss of function assays of LEF1-AS1 and miR-222-5p were conducted. Cell viability and apoptosis of microglial cells were assessed via CCK8 assay and flow cytometry, respectively. Adult Sprague-Dawley (SD) rats were randomly divided into four groups: Control, SCI, sh-NC, and sh-LEF-AS1 groups. ELISA test was used to determine the expression of TNF-α and IL-6, whereas the protein level of apoptotic-related markers (Bcl-2, Bax, and cleaved caspase-3) was assessed using Western blot technique. Results We revealed that LncRNA LEF1-AS1 was distinctly upregulated, whereas miR-222-5p was significantly downregulated in LPS-treated SCI and microglial cells. However, LEF1-AS1 knockdown enhanced cell viability, inhibited apoptosis, as well as inflammation of LPS-mediated microglial cells. On the contrary, miR-222-5p upregulation decreased cell viability, promoted apoptosis, and inflammation of microglial cells. Mechanistically, LEF1-AS1 served as a competitive endogenous RNA (ceRNA) by sponging miR-222-5p, targeting RAMP3. RAMP3 overexpression attenuated LEF1-AS1-mediated protective effects on LPS-mediated microglial cells from apoptosis and inflammation. Conclusion In summary, these findings ascertain that knockdown of LEF1-AS1 impedes SCI progression via the miR-222-5p/RAMP3 axis.


Polymers ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 2245
Author(s):  
Jue-Zong Yeh ◽  
Ding-Han Wang ◽  
Juin-Hong Cherng ◽  
Yi-Wen Wang ◽  
Gang-Yi Fan ◽  
...  

In spinal cord injury (SCI) therapy, glial scarring formed by activated astrocytes is a primary problem that needs to be solved to enhance axonal regeneration. In this study, we developed and used a collagen scaffold for glial scar replacement to create an appropriate environment in an SCI rat model and determined whether neural plasticity can be manipulated using this approach. We used four experimental groups, as follows: SCI-collagen scaffold, SCI control, normal spinal cord-collagen scaffold, and normal control. The collagen scaffold showed excellent in vitro and in vivo biocompatibility. Immunofluorescence staining revealed increased expression of neurofilament and fibronectin and reduced expression of glial fibrillary acidic protein and anti-chondroitin sulfate in the collagen scaffold-treated SCI rats at 1 and 4 weeks post-implantation compared with that in untreated SCI control. This indicates that the collagen scaffold implantation promoted neuronal survival and axonal growth within the injured site and prevented glial scar formation by controlling astrocyte production for their normal functioning. Our study highlights the feasibility of using the collagen scaffold in SCI repair. The collagen scaffold was found to exert beneficial effects on neuronal activity and may help in manipulating synaptic plasticity, implying its great potential for clinical application in SCI.


Sign in / Sign up

Export Citation Format

Share Document